Condylomata acuminata (CA), or genital warts, is one of the most common sexually transmitted diseases caused by infection with the human papillomavirus (HPV), in particular, HPV types 6 and 11 (1) . CA is diagnosed by visual inspection for the presence of lesions consistent with warts, sometimes using pathologic examination (2). During pregnancy, there is a tendency for CA to proliferate because of physiological changes to the external genitalia, and immunological effects that promote HPV replication (3, 4) . Conditions in which there is down-regulation of cell-mediated immunity, such as pregnancy, are associated with more severe disease. The principal symptoms of CA are unsightly, uncomfortable, and psychologically traumatic (1) . Additionally, during delivery, CA can cause massive hemorrhage, complicate the repair of obstetric lacerations, and increase the risk of neonatal HPV infection.
Transmission of HPV to a neonate can result in laryngeal papillomatosis in the newborn, such as juvenileonset recurrent respiratory papillomatosis (JORRP) (4) (5) (6) . This is a rare and non-malignant condition, and it is unclear whether the newborn becomes infected during birth or postpartum. As a result, guidelines issued by the USA Center for Disease Control and Prevention (CDC) do not strongly recommend cesarean section for the prevention of neonatal HPV infection (2) . Therefore, in the USA, cesarean section is only indicated for women with CA if the pelvic outlet is obstructed or if vaginal delivery may result in excessive bleeding. On the other hand, the Guideline for Gynecological Practice in Japan 2014 (7) advocates cesarean delivery for pregnant women with CA, especially in cases with vaginal warts, providing that fully informed consent has been given. This should include information on the possibility of increased risks of JORRP associated with vaginal/ cesarean delivery, or following rupture of the membranes during labor. Based on this background, therapeutic strategies for CA during pregnancy have not been fully determined.
The first aim of our study was to evaluate the current prevalence of CA among pregnant women in Japan.
The second aim was to examine the current management of CA-affected pregnant women in Japan. The protocol for this study was approved by the Ethics Committee of the Japan Association of Obstetricians and Gynecologists (JAOG).
In September 2015, we contacted 2,501 facilities with JAOG membership, requesting information on CA in pregnant women who delivered at 22 weeks' gestation between January 1 and June 30, 2015. One thousand eight hundred and forty-six (73.8z) obstetrical facilities responded with information on a total of 244,887 women. This accounted for approximately 50z of all deliveries that occurred in Japan during the study period (approximately 500,000 births per 6 months).
In addition to the prevalence of CA, we made inquiries concerning: (i) delivery modes (or indications for cesarean section) in pregnant women with CA, (ii) methods of CA treatment during pregnancy, and (iii) provision of information regarding JORRP to pregnant women with CA.
During statistical analysis, the x 2 or Fisher's exact test was used for categorical variables. Differences with p ＜ 0.05 were considered significant. Table 1 shows the distribution of CA-infected pregnant women and the rates of cesarean delivery due to CA in Japan, stratified by maternal age. The total rates of CA-infected pregnant women and the rate of cesarean delivery were 1/444 (225 in 100,000) and 1/2,369 (42 in 100,000), respectively. In addition, the prevalence of cesarean delivery due to CA was higher in teenaged pregnant women than in women aged 20 years (p ＜ 0.01), and higher in women aged 20-29 years than in those aged 30 years (p ＜ 0.01). The overall rate of cesarean delivery in pregnant women experiencing CA was 18.8z (108/576). There were no significant differences in the rates of cesarean delivery between maternal age groups.
Of the 1,846 obstetrical facilities that provided data, 1,582 (85.7z) responded to our additional inquiries. Two hundred facilities (12.6z) reported that they attempted vaginal delivery in all cases of CA, 317 facilities (20.0z) elected cesarean delivery in cases at high risk of massive hemorrhage, 825 facilities (52.1z) elected cesarean section in all cases with vaginal warts, and 240 facilities (15.2z) elected cesarean section in cases where condyloma lesions were present. There were no significant differences in the methods of treatment (Table 2) . However, significant differences were found in rates of facilities providing information to pregnant women with CA. Some facilities were up to 4.3 (range: 23.0-5.4z, p ＜ 0.01) times more likely than others to not provide information about JORRP, and up 72 (range: 1.0-72.3z, p ＜ 0.01) times more likely than others to not provide information about cesarean deliveries.
Ours may be the first report concerning the status of CA infection in pregnant women in Japan.
The current prevalence of CA in pregnant women, with even higher rates among teenagers, is comparable to some previous observations in a range of sexually transmitted infections (8) (9) (10) (11) (12) (13) . In previous studies that reported age-based estimates, younger participants showed higher prevalence of HPV or CA than older participants. This was associated with cervical biological immaturity (11) and sexual behavior, because numbers of sexual partners are highest in the younger age groups (12) . For example, in an earlier study in Japan (13), the incidences of HPV infection in women aged 15-19, 20-24, 25-29, and 30 years were 44, 29, 20, and 7z, respectively. In our previous study (14) , the incidence of abnormal uterine cervical cytology in pregnant women aged 16 years was 10z, which was significantly higher than in women aged 20-29 years (1.2z). Therefore, it appears that younger women exhibit a higher prevalence of HPV infection. The earlier study in Japan (13) reported that the HPV infection rate was observed to fall markedly from around 30-35 years of age, which may correspond to the Japanese social phenomenon whereby the average age of marriage is over 30 years. It is feared that HPV infection is becoming more prevalent in young couples in accordance with the adoption of increasingly Westernized lifestyles.
It is recommended that the treatment strategy for CA during pregnancy be based on the size, location, distribution, and number of lesions (1) (2) (3) (4) . Most therapeutic modalities require multiple treatments with frequent follow-up. A variety of treatment options exist. No data have suggested superiority of one treatment over another. When making their decision, patients should be informed about the success rates and potential risks and complications associated with each treatment. Although we have identified several different approaches to indication for cesarean section, no significant differences in therapeutic principles were found among Japanese obstetrical facilities (Table 2) . Imiquimod 5z cream was prescribed to around 40z of the pregnant women with CA in this study. Other major medical drugs such as tricholoric acids or podophyllin derivatives, which are used principally in the USA (4, 15) , are not sold in Japan. Imiquimod has been reported to stimulate cell-mediated immunity and induce the production of cytokines with antiviral activity, which destroy the HPV-infected cells within condyloma lesions. However, the drug cannot be used for intravaginal diseases (15) ; therefore, we found that surgical treat-ments (including cryotherapy) were the main topical therapies used during pregnancy (Table 2 ).
Our results demonstrate that differences in facilities' use of indications for cesarean section may contribute to differences in awareness of the risk posed by laryngeal papillomatosis in newborns, such as JORRP, among pregnant women with CA. JORRP is the most common benign neoplasm of the larynx in children, and can cause childhood hoarseness, a change in voice, chronic cough, choking, recurrent respiratory infections, and failure to thrive (4) (5) (6) 16) . Treatment primarily consists of surgical removal, although recurrence is common. Cesarean section should be discussed as an option with CA-affected pregnant women, although they must be made aware that it is not always protective against neonatal HPV infection. Cases of CA-affected women with delivery times of more than 10 hours have been associated with a 2-fold increased risk of neonatal respiratory papillomatosis (5) . Therefore, in cases of severe disease, vaginal delivery may be unsuitable, although we believe that there is no indication for cesarean delivery if the case of CA is mild. Guidelines for determining the severity of CA associated with the risk of HPV transmission at delivery may be needed.
Other limitations include potential inaccuracies in the diagnosis of CA, because it is based principally on visual inspection for the presence of lesions. Indications for cesarean section in women with CA should be clarified by accumulating information on cases that meet the predetermined diagnosis and strategy for CA during pregnancy. A large prospective study may be needed.
